Advertisement
Screener

THE PENNANT GROUP, INC. (PNTG) Noncontrolling Interest, Increase from Subsidiary Equity Issuance

2.8 / 5 stars · 68/120 Roast Me

THE PENNANT GROUP, INC. Noncontrolling Interest, Increase from Subsidiary Equity Issuance

THE PENNANT GROUP, INC. (PNTG) reported Noncontrolling Interest, Increase from Subsidiary Equity Issuance of $594.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2022-02-28.

Discontinued › Shareholders' Equity › Noncontrolling Interest Items

us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance · last filed 2022-02-28

  • THE PENNANT GROUP, INC. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2019-09-30 was $17.00K, a 95.11% decline year-over-year.
  • THE PENNANT GROUP, INC. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2019-06-30 was $236.00K, a 31.40% decline year-over-year.
  • THE PENNANT GROUP, INC. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2019-03-31 was $341.00K, a 0.89% increase year-over-year.
  • THE PENNANT GROUP, INC. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2018-09-30 was $348.00K.
  • THE PENNANT GROUP, INC. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2019 was $594.00K, a 56.89% decline from fiscal 2018.
  • THE PENNANT GROUP, INC. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2018 was $1.38M, a 1.03% increase from fiscal 2017.
  • THE PENNANT GROUP, INC. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2017 was $1.36M.
Period endNoncontrolling Interest, Increase from Subsidiary Equity Issuance 3 monthNoncontrolling Interest, Increase from Subsidiary Equity Issuance 6 monthNoncontrolling Interest, Increase from Subsidiary Equity Issuance 9 monthNoncontrolling Interest, Increase from Subsidiary Equity Issuance 12 month
2019-12-31$594.00K
10-K · filed 2022-02-28
2019-09-30$17.00K
10-Q · filed 2020-11-10
$253.00K
derived: sum of 2 quarters · filed 2020-11-10
$594.00K
derived: sum of 3 quarters · filed 2020-11-10
2019-06-30$236.00K
10-Q · filed 2020-11-10
$577.00K
derived: sum of 2 quarters · filed 2020-11-10
2019-03-31$341.00K
10-Q · filed 2020-11-10
2018-12-31$1.38M
10-K · filed 2021-02-24
2018-09-30$348.00K
10-Q · filed 2019-11-12
$692.00K
derived: sum of 2 quarters · filed 2019-11-12
$1.03M
derived: sum of 3 quarters · filed 2019-11-12
2018-06-30$344.00K
10-Q · filed 2019-11-12
$682.00K
derived: sum of 2 quarters · filed 2019-11-12
2018-03-31$338.00K
10-Q · filed 2019-11-12
2017-12-31$1.36M
10-K · filed 2020-03-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Omada Health, Inc. (OMDA)United States$1.207B309.08
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
GeneDx Holdings Corp. (WGS)United States$2.638B-19.23
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86